POU5F1 and granular cell tumor: In our series, we had only one case of mixed GCT with components of EC and YSTs with a loss of OCT3/4 expression and subsequent cisplatin resistance, resulting in death 17 months after diagnosis, which aligns with Mueller et al.‘s results.